MedTrace Logo

Effects of Resveratrol Supplements on Vascular Health in Postmenopausal Women

NCT01564381 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2017-07-14

No results posted yet for this study

Summary

The investigators hope to learn if resveratrol supplementation can be beneficial for the cardiovascular system. Seeing that resveratrol is rapidly metabolized, the investigators are interested in learning if a novel form of resveratrol, ResA, which is a mixture of resveratrol with amino acid, may have greater bioavailability and lead to greater improvement in vascular function, compared to standard resveratrol supplement.

Conditions

Interventions

DIETARY_SUPPLEMENT

ResA

90mg of resveratrol conjugated with arginine.

DIETARY_SUPPLEMENT

Resveratrol

90mg of resveratrol.

DIETARY_SUPPLEMENT

Placebo

Made up of cellulose.

Sponsors & Collaborators

  • Gateway Health Alliance

    collaborator INDUSTRY

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Robert M Hackman, PhD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01564381 on ClinicalTrials.gov